Sir Frederick Banting

from £30.00

At times serious, often light-hearted and always colourful, Diabetes by Design is a collection of of playful giclée prints inspired by the highs and lows of living with type 1 diabetes.

The prints are available in A3 or A4 and are printed on textured acid-free white heavyweight paper. Each print is signed, sold unframed and supplied flat with a grey board backing.

Each purchased print helps us to produce our Companion Cards, an affordable toolkit to address the emotional and mental toll of living with type 1 diabetes, thank you.

Sizes A3 (297 x 420mm), A4 (210 x 297mm)
Paper 300 gsm textured white
Printing Giclée

Signed by the artist
Sold unframed
Made in the UK, shipped all over the world

Size:

At times serious, often light-hearted and always colourful, Diabetes by Design is a collection of of playful giclée prints inspired by the highs and lows of living with type 1 diabetes.

The prints are available in A3 or A4 and are printed on textured acid-free white heavyweight paper. Each print is signed, sold unframed and supplied flat with a grey board backing.

Each purchased print helps us to produce our Companion Cards, an affordable toolkit to address the emotional and mental toll of living with type 1 diabetes, thank you.

Sizes A3 (297 x 420mm), A4 (210 x 297mm)
Paper 300 gsm textured white
Printing Giclée

Signed by the artist
Sold unframed
Made in the UK, shipped all over the world

The inspiration behind the artwork

Access to insulin is political

This print was designed for the 17th May 2021 and is a homage to Shepard Fairey’s Hope poster for Obama’s 2008 presidential campaign. This political design felt fitting in celebrating 100 years since Sir Frederick Banting’s life-changing discovery and the ongoing issue that over 50% of people living with type 1 diabetes cannot reliably access insulin because it is either unavailable, unaffordable or both.

Diabetes by Design is donating 20% of sales of this print to T1International, a non-profit organisation focused on making access to insulin a reality for all.